Trials / Conditions / Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
6 registered clinical trials studyying Primary Cutaneous T-Cell Non-Hodgkin Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma NCT07356245 | Jonathan Brammer | Phase 2 |
| Recruiting | Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810 | Mayo Clinic | Phase 1 |
| Recruiting | Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653 | City of Hope Medical Center | Phase 2 |
| Terminated | Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides NCT04676087 | Emory University | Phase 1 / Phase 2 |
| Completed | Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Trea NCT04312841 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma NCT01000753 | Children's Oncology Group | — |